These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32497961)

  • 1. Pharmacomodulations of the benzoyl-thiosemicarbazide scaffold reveal antimicrobial agents targeting d-alanyl-d-alanine ligase in bacterio.
    Ameryckx A; Pochet L; Wang G; Yildiz E; Saadi BE; Wouters J; Van Bambeke F; Frédérick R
    Eur J Med Chem; 2020 Aug; 200():112444. PubMed ID: 32497961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-(2-Hydroxybenzoyl)-thiosemicarbazides are promising antimicrobial agents targeting d-alanine-d-alanine ligase in bacterio.
    Ameryckx A; Thabault L; Pochet L; Leimanis S; Poupaert JH; Wouters J; Joris B; Van Bambeke F; Frédérick R
    Eur J Med Chem; 2018 Nov; 159():324-338. PubMed ID: 30300845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ellipticines and 9-acridinylamines as inhibitors of D-alanine:D-alanine ligase.
    Vehar B; Hrast M; Kovač A; Konc J; Mariner K; Chopra I; O'Neill A; Janežič D; Gobec S
    Bioorg Med Chem; 2011 Sep; 19(17):5137-46. PubMed ID: 21831641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of new cyanothiophene inhibitors of the essential peptidoglycan biosynthesis enzyme MurF.
    Hrast M; Turk S; Sosič I; Knez D; Randall CP; Barreteau H; Contreras-Martel C; Dessen A; O'Neill AJ; Mengin-Lecreulx D; Blanot D; Gobec S
    Eur J Med Chem; 2013 Aug; 66():32-45. PubMed ID: 23786712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and evaluation of second generation MurF inhibitors based on a cyanothiophene scaffold.
    Hrast M; Anderluh M; Knez D; Randall CP; Barreteau H; O'Neill AJ; Blanot D; Gobec S
    Eur J Med Chem; 2014 Feb; 73():83-96. PubMed ID: 24384549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-Arylpyrido[2,3-d]pyrimidines as novel ATP-competitive inhibitors of bacterial D-alanine:D-alanine ligase.
    Škedelj V; Arsovska E; Tomašić T; Kroflič A; Hodnik V; Hrast M; Bešter-Rogač M; Anderluh G; Gobec S; Bostock J; Chopra I; O'Neill AJ; Randall C; Zega A
    PLoS One; 2012; 7(8):e39922. PubMed ID: 22876277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel antibacterial agents: Recent developments in D-alanyl-D-alanine ligase inhibitors.
    Qin Y; Xu L; Teng Y; Wang Y; Ma P
    Chem Biol Drug Des; 2021 Sep; 98(3):305-322. PubMed ID: 34047462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of d-boroAla as a novel broad-spectrum antibacterial agent targeting d-Ala-d-Ala ligase.
    Putty S; Rai A; Jamindar D; Pagano P; Quinn CL; Mima T; Schweizer HP; Gutheil WG
    Chem Biol Drug Des; 2011 Nov; 78(5):757-63. PubMed ID: 21827632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphinate inhibitors of UDP-N-acetylmuramoyl-L-alanyl-D-glutamate: L-lysine ligase (MurE).
    Strancar K; Boniface A; Blanot D; Gobec S
    Arch Pharm (Weinheim); 2007 Mar; 340(3):127-34. PubMed ID: 17335103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diazenedicarboxamides as inhibitors of D-alanine-D-alanine ligase (Ddl).
    Kovac A; Majce V; Lenarsic R; Bombek S; Bostock JM; Chopra I; Polanc S; Gobec S
    Bioorg Med Chem Lett; 2007 Apr; 17(7):2047-54. PubMed ID: 17267218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of new inhibitors of D-alanine:D-alanine ligase by structure-based virtual screening.
    Kovac A; Konc J; Vehar B; Bostock JM; Chopra I; Janezic D; Gobec S
    J Med Chem; 2008 Dec; 51(23):7442-8. PubMed ID: 19053785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. d-Alanyl-d-Alanine Ligase as a Broad-Host-Range Counterselection Marker in Vancomycin-Resistant Lactic Acid Bacteria.
    Zhang S; Oh JH; Alexander LM; Özçam M; van Pijkeren JP
    J Bacteriol; 2018 Jul; 200(13):. PubMed ID: 29686137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATP competitive inhibitors of D-alanine-D-alanine ligase based on protein kinase inhibitor scaffolds.
    Triola G; Wetzel S; Ellinger B; Koch MA; Hübel K; Rauh D; Waldmann H
    Bioorg Med Chem; 2009 Feb; 17(3):1079-87. PubMed ID: 18321716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis ADMET and molecular docking of new imidazo[4,5-b]pyridine-5-thione derivatives as potential tyrosyl-tRNA synthetase inhibitors.
    Othman IMM; Gad-Elkareem MAM; Hassane Anouar E; Aouadi K; Kadri A; Snoussi M
    Bioorg Chem; 2020 Sep; 102():104105. PubMed ID: 32717689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Chlamydia MurC-Ddl, a fusion protein exhibiting D-alanyl-D-alanine ligase activity involved in peptidoglycan synthesis and D-cycloserine sensitivity.
    McCoy AJ; Maurelli AT
    Mol Microbiol; 2005 Jul; 57(1):41-52. PubMed ID: 15948948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mur ligases inhibitors with azastilbene scaffold: Expanding the structure-activity relationship.
    Hrast M; Frlan R; Knez D; Zdovc I; Barreteau H; Gobec S
    Bioorg Med Chem Lett; 2021 May; 40():127966. PubMed ID: 33744441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of N-acylhydrazones as inhibitors of MurC and MurD ligases.
    Sink R; Kovac A; Tomasić T; Rupnik V; Boniface A; Bostock J; Chopra I; Blanot D; Masic LP; Gobec S; Zega A
    ChemMedChem; 2008 Sep; 3(9):1362-70. PubMed ID: 18651694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the Mycobacterium tuberculosis D-alanine:D-alanine ligase, a target of the antituberculosis drug D-cycloserine.
    Bruning JB; Murillo AC; Chacon O; Barletta RG; Sacchettini JC
    Antimicrob Agents Chemother; 2011 Jan; 55(1):291-301. PubMed ID: 20956591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Benzylidenethiazolidin-4-ones as multitarget inhibitors of bacterial Mur ligases.
    Tomasić T; Zidar N; Kovac A; Turk S; Simcic M; Blanot D; Müller-Premru M; Filipic M; Grdadolnik SG; Zega A; Anderluh M; Gobec S; Kikelj D; Peterlin Masic L
    ChemMedChem; 2010 Feb; 5(2):286-95. PubMed ID: 20024979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Halogenation of Biotin Protein Ligase Inhibitors Improves Whole Cell Activity against Staphylococcus aureus.
    Paparella AS; Lee KJ; Hayes AJ; Feng J; Feng Z; Cini D; Deshmukh S; Booker GW; Wilce MCJ; Polyak SW; Abell AD
    ACS Infect Dis; 2018 Feb; 4(2):175-184. PubMed ID: 29131575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.